Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10355299rdf:typepubmed:Citationlld:pubmed
pubmed-article:10355299lifeskim:mentionsumls-concept:C0025936lld:lifeskim
pubmed-article:10355299lifeskim:mentionsumls-concept:C1336745lld:lifeskim
pubmed-article:10355299lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:10355299lifeskim:mentionsumls-concept:C0034790lld:lifeskim
pubmed-article:10355299lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:10355299lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:10355299lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:10355299lifeskim:mentionsumls-concept:C2699787lld:lifeskim
pubmed-article:10355299pubmed:issue2lld:pubmed
pubmed-article:10355299pubmed:dateCreated1999-8-3lld:pubmed
pubmed-article:10355299pubmed:abstractTextThe abrogation of apoptosis during development of thymocytes could contribute to the lymphomagenesis of immature thymocytes which otherwise would be deleted. In agreement with this possibility it was found that cells of thymic lymphomas from TCR anty H-Y transgenic mice were resistant to TCR mediated apoptosis. Molecular mechanism responsible for resistance to TCR/Nur77-mediated apoptosis in these lymphomas is discussed.lld:pubmed
pubmed-article:10355299pubmed:languagepollld:pubmed
pubmed-article:10355299pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10355299pubmed:citationSubsetIMlld:pubmed
pubmed-article:10355299pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10355299pubmed:statusMEDLINElld:pubmed
pubmed-article:10355299pubmed:issn0032-5449lld:pubmed
pubmed-article:10355299pubmed:authorpubmed-author:Strzada?aLLlld:pubmed
pubmed-article:10355299pubmed:issnTypePrintlld:pubmed
pubmed-article:10355299pubmed:volume53lld:pubmed
pubmed-article:10355299pubmed:ownerNLMlld:pubmed
pubmed-article:10355299pubmed:authorsCompleteYlld:pubmed
pubmed-article:10355299pubmed:pagination345-50lld:pubmed
pubmed-article:10355299pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10355299pubmed:meshHeadingpubmed-meshheading:10355299...lld:pubmed
pubmed-article:10355299pubmed:meshHeadingpubmed-meshheading:10355299...lld:pubmed
pubmed-article:10355299pubmed:meshHeadingpubmed-meshheading:10355299...lld:pubmed
pubmed-article:10355299pubmed:meshHeadingpubmed-meshheading:10355299...lld:pubmed
pubmed-article:10355299pubmed:meshHeadingpubmed-meshheading:10355299...lld:pubmed
pubmed-article:10355299pubmed:meshHeadingpubmed-meshheading:10355299...lld:pubmed
pubmed-article:10355299pubmed:meshHeadingpubmed-meshheading:10355299...lld:pubmed
pubmed-article:10355299pubmed:meshHeadingpubmed-meshheading:10355299...lld:pubmed
pubmed-article:10355299pubmed:year1999lld:pubmed
pubmed-article:10355299pubmed:articleTitle[Disturbance of signalling pathways for apoptosis in thymic lymphomas from TCR transgenic mice].lld:pubmed
pubmed-article:10355299pubmed:affiliationLaboratorium Immunologii Komórkowej, Instytutu Immunologii i Terapii Do?wiadczalnej PAN, Wroc?awiu.lld:pubmed
pubmed-article:10355299pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10355299pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:10355299pubmed:publicationTypeReviewlld:pubmed